PIPELINE OVERVIEW

We have a robust drug development pipeline at various clinical and preclinical stages.

Download Pipeline

Tap the sections below to expand or download the full pipeline chart.

LAST STAGE

LAST STAGE

INVESTOR INITIATED IO

INVESTOR INITIATED IO

OTHER ONCOLOGY PIPELINE

OTHER ONCOLOGY PIPELINE
1) Dalian Wanchunbulin Pharmaceuticals Ltd., a BeyondSpring subsidiary, owns Greater China rights to Plinabulin
2) BeyondSpring is an equity investor of SEED Therapeutics, a targeted protein degradation company.